4-Bromo-6-fluoro-2-(trifluoromethyl)quinoline is a heterocyclic organic compound characterized by its quinoline backbone, which consists of a fused benzene and pyridine ring. The presence of a bromine atom at the 4-position and a fluorine atom at the 6-position contributes to its unique reactivity and potential applications in medicinal chemistry. Additionally, the trifluoromethyl group at the 2-position enhances its lipophilicity and metabolic stability, making it an interesting candidate for drug development. This compound is typically synthesized through halogenation and functionalization reactions, and it may exhibit biological activity, including antimicrobial or anticancer properties, due to the presence of halogen substituents. Its molecular structure allows for various interactions with biological targets, which can be explored in pharmaceutical research. As with many fluorinated compounds, it may also exhibit distinct physical properties, such as increased boiling and melting points compared to non-fluorinated analogs. Safety and handling precautions should be observed due to the potential toxicity of halogenated compounds.

4-bromo-6-fluoro-2(trifluoromethyl)quinoline

31009-33-3: 4-Bromo-6-fluoro-2-(trifluoromethyl)quinoline is a heterocyclic organic compound characterized by its quinoline backbone, which consists of a fused benzene and pyridine ring. The presence of a bromine atom at the 4-position and a fluorine atom at the 6-position contributes to its unique reactivity and potential applications in medicinal chemistry. Additionally, the trifluoromethyl group at the 2-position enhances its lipophilicity and metabolic stability, making it an interesting candidate for drug development. This compound is typically synthesized through halogenation and functionalization reactions, and it may exhibit biological activity, including antimicrobial or anticancer properties, due to the presence of halogen substituents. Its molecular structure allows for various interactions with biological targets, which can be explored in pharmaceutical research. As with many fluorinated compounds, it may also exhibit distinct physical properties, such as increased boiling and melting points compared to non-fluorinated analogs. Safety and handling precautions should be observed due to the potential toxicity of halogenated compounds.

CAS 31009-33-3

4-bromo-6-fluoro-2(trifluoromethyl)quinoline

Quinoline, 4-bromo-6-fluoro-2-(trifluoromethyl)-

Ref: IN-DA0031X3

4-Bromo-6-fluoro-2-(trifluoromethyl)quinoline

Ref: 10-F215902